Alzheimer’s drugs offer little benefit, major review finds – and the reasons go deeper than the science

The Conversation The Conversation

Alzheimer’s research shows what happens when funding pressures and vested interests corrupt the pursuit of scientific truth.

Read full article at The Conversation →